Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.
about
In Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid LibrariesPros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesNanobody: the "magic bullet" for molecular imaging?Therapeutic antibody engineering by high efficiency cell screening.Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging.Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli.STED microscopy: increased resolution for medical research?Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development.Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's disease.Improving the targeting of therapeutics with single-domain antibodies.Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma.Emerging site-specific bioconjugation strategies for radioimmunotracer development.Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.Camelid reporter gene imaging: a generic method for in vivo cell trackingSpecific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis.Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.Al18F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging.Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies.Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells.Immunoengineering with biomaterials for enhanced cancer immunotherapy.Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model.A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis.Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment.Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.
P2860
Q26782129-925F322E-DC4E-40A0-AB13-FD617204C1BBQ27013679-4C01105D-4B51-4B21-96E9-77B4E1EE3E6EQ30442626-D6225BBE-6C94-4CA6-AAEB-669E1A9AF837Q35056966-C87BE95C-C754-4F18-914D-E4F93C5A3131Q35674555-5BD3702A-9430-4EDD-B8AC-87811FF0E10EQ37085052-880EACB6-64E5-4054-B198-20FD3FCE94E3Q37283860-2BF8096C-4113-4FB0-82D7-341CC4231154Q38224901-2562C2B8-175D-403A-ABE2-D7BCAA249FB5Q38230884-81A2635A-3E6A-4806-8B33-0522EC82FE6CQ38236706-44F54B68-B474-4323-8571-FC90A691C276Q38665688-1780C981-0D66-4F25-BABF-80C0AD16C496Q38675117-D99077FF-3A40-41EC-9DA9-C81623666C4CQ38797038-A8F7086D-71AF-41FA-810A-72228B34F858Q38818208-5E7D20F8-295D-47CF-937A-D8065DEC7FD6Q38836740-250F16BB-5D47-42CA-AC38-2A8FE5E2BDC2Q38975295-1288A37E-E73B-4185-ACD0-F37D16C63869Q39218666-075AC380-69C6-47ED-B9F6-74E39FBF19EAQ39437960-F294B9A6-58A5-4A17-BA00-D4DB59ACEB43Q39793253-5496DA22-984C-4125-B4F8-B78C93F8F05BQ41455532-17D88198-167E-4BF1-818A-593911DC9DCEQ45729133-BBEE2D43-870D-4F3B-844B-75A3048BFF57Q47099672-A2890500-2811-48EB-B77B-D839112FE307Q47150050-D4FA9276-1795-45AE-A427-0E37682DE5E9Q47732542-322D83BE-A8A3-4241-A1C6-9CC30B56577BQ48091253-A3495660-7352-4C8F-ABF1-FD603BF2B6CDQ48509449-751E8C1C-71DD-42EB-9ED4-F78BD4FD134AQ49040689-2C1A5289-6E69-4859-A7A3-FDF3CE035BE1Q49079310-79E38034-A524-4FF8-86F5-500D2258BA89Q49167649-5729101A-4A94-4888-9BEB-26FDAE15EC43Q55021294-BC818FFF-ABE2-4AC1-9946-2FBC098EC66F
P2860
Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Camelid single-domain antibody ...... ting the bullet to its target.
@en
type
label
Camelid single-domain antibody ...... ting the bullet to its target.
@en
prefLabel
Camelid single-domain antibody ...... ting the bullet to its target.
@en
P2860
P1476
Camelid single-domain antibody ...... ting the bullet to its target.
@en
P2093
Jens De Vos
Tony Lahoutte
P2860
P304
P356
10.1517/14712598.2013.800478
P407
P577
2013-05-16T00:00:00Z